Oxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation

Cell Death and Differentiation

Volumn 21, Issue 7, 2014, Pages 1107-1118

  Peuget, S ^a   Bonacci, T ^a   Soubeyran, P ^a   Iovanna, J ^a   Dusetti, N J ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CBX4 PROTEIN; LIGASE; LYSINE; PIAS3 PROTEIN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; PROTEINASE; PUMA PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 6 PROTEIN; TUMOR PROTEIN P53 INDUCED NUCLEAR PROTEIN 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CBX4 PROTEIN, HUMAN; CHAPERONE; HEAT SHOCK PROTEIN; PIAS3 PROTEIN, HUMAN; POLYCOMB GROUP PROTEIN; PROTEIN INHIBITOR OF ACTIVATED STAT; SERINE PROTEINASE; SUMO1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TP53INP1 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; AUTOPHAGY; CELL CYCLE ARREST; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SUMOYLATION; AMINO ACID SEQUENCE; CELL PROLIFERATION; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; AUTOPHAGY; CARRIER PROTEINS; CELL PROLIFERATION; HEAT-SHOCK PROTEINS; HEK293 CELLS; HUMANS; MCF-7 CELLS; MOLECULAR CHAPERONES; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYCOMB-GROUP PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; SERINE ENDOPEPTIDASES; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 84902239677     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.28     Document Type: Article

References (40)

1. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305.
2. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126: 121-134.
3. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O et al. p53 regulates mitochondrial respiration. Science 2006; 312: 1650-1653.
4. Roger L, Gadea G, Roux P. Control of cell migration: a tumour suppressor function for p53? Biol Cell 2006; 98: 141-152.
5. Teodoro JG, Parker AE, Zhu X, Green MR. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science 2006; 313: 968-971.
6. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 2007; 450: 721-724.
7. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413-431.
8. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107: 9660-9664.
9. Kang HN, Oh SC, Kim JS, Yoo YA. Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Exp Cell Res 2012; 318: 539-549.
10. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 2001; 8: 85-94.
11. Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC et al. P53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol 2002; 81: 294-301.
12. Tomasini R, Samir AA, Vaccaro MI, Pebusque MJ, Dagorn JC, Iovanna JL et al. Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. J Biol Chem 2001; 276: 44185-44192.
13. Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S et al. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 2003; 278: 37722-37729.
14. Yoshida K, Liu H, Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 2006; 281: 5734-5740.
15. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 2007; 104: 16170-16175.
16. Gommeaux J, Cano C, Garcia S, Gironella M, Pietri S, Culcasi M et al. Colitis and colitisassociated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 2007; 27: 2215-2228.
17. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M et al. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 2009; 69: 219-226.
18. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J 2005; 24: 3353-3359.
19. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 2005; 6: 599-609.
20. Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 2006; 22: 159-180.
21. Seeler JS, Dejean A. Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 2003; 4: 690-699.
22. Verger A, Perdomo J, Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep 2003; 4: 137-142.
23. Hay RT. SUMO: a history of modification. Mol Cell 2005; 18: 1-12.
24. Rodriguez MS, Dargemont C, Hay RT. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 2001; 276: 12654-12659.
25. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem 2001; 276: 21664-21669.
26. Bossis G, Melchior F. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol Cell 2006; 21: 349-357.
27. Seillier M, Peuget S, Gayet O, Gauthier C, N'Guessan P, Monte M et al. TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3- interacting region (LIR) and promotes autophagy-dependent cell death. Cell Death Differ 2012; 19: 1525-1535.
28. Sancho A, Duran J, Garcia-Espana A, Mauvezin C, Alemu EA, Lamark T et al. DOR/ Tp53inp2 and Tp53inp1 constitute a metazoan gene family encoding dual regulators of autophagy and transcription. PLoS One 2012; 7: e34034.
29. Hickey CM, Wilson NR, Hochstrasser M. Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol 2012; 13: 755-766.
30. Shen LN, Dong C, Liu H, Naismith JH, Hay RT. The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem J 2006; 397: 279-288.
31. Reverter D, Lima CD. Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol 2006; 13: 1060-1068.
32. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 2005; 11: 1306-1313.
33. Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999; 18: 6145-6157.
34. Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 2008; 9: 702-712.
35. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004; 304: 596-600.
36. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752.
37. Hershko T, Chaussepied M, Oren M, Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 2005; 12: 377-383.
38. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008; 68: 8976-8985.
39. Enomoto Y, Kitaura J, Hatakeyama K, Watanuki J, Akasaka T, Kato N et al. Emu/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia 2011; 25: 1849-1856.
40. Bomben R, Gobessi S, Dal Bo M, Volinia S, Marconi D, Tissino E et al. The miR-17 approximately 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia 2012; 26: 1584-1593.